FORT WORTH, Texas, Oct. 7 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), a rapidly growing provider of specialty medical products, announced today that the company will actively participate at the Save A Leg, Save a Life Foundation National Conference (SALSAL) that opens in Orlando tomorrow, October 8.
In addition to exhibiting its CellerateRX Technology at the conference, the company will conduct a workshop entitled "The Benefits of Collagen in Wound Healing: Methods of Action and Selection of Collagen Containing Dressings." The discussion will include the role of activated collagen product CellerateRX in wound management and how it differs from other collagen products.
Scott Haire, CEO of Wound Management Technologies, said, "Wound Management Technologies, through two subsidiaries, is participating in one of the fastest growing medical markets worldwide. The total global biomaterials market is currently $28 billion and is expected to exceed $58 billion in the next five years. The orthopedic biomaterials market is approximately $10 billion alone, driven by improved patient benefits, a shorter FDA approval cycle, and an aging population ever more aware of biomaterial benefits."
"We are delighted to be exhibiting at the SALSAL conference," states Cathy Bradshaw, President of Wound Care Innovations. "Diabetic wounds and the incidence of amputations is a serious issue in healthcare. The financial impact on the healthcare system is astronomical and the quality of life issues for patients are immeasurable. Wound care products that can manage these wounds effectively can help save limbs. Studies continue to support CellerateRx®'s effectiveness in diabetic and other wounds."
About Save a Leg, Save a Life Foundation
The mission of Save A Leg, Save A Life Foundation is to reduce the number of lower extremity amputations and to improve the quality of life of those afflicted with wounds. The foundation uses advanced evidence based methods and is dedicated to educating practitioners and patients through community outreach efforts. The organization supports collegial cooperation among those seeking improved solutions in the treatment of wounds. Scientific results from the Save A Leg, Save A Life founding chapter in Jacksonville, FL. and additional may be found by visiting http://savealegsavealife.com
About Wound Management Technologies, Inc.
Wound Management Technologies, through its subsidiary Wound Care Innovations, markets and distributes wound care products to the healthcare market under patented technology licensed to the company. The company is positioned and seeks to be a leading provider of wound care products. The company's corporate headquarters are in Fort Worth, Texas. For more information please visit the company's website at www.celleraterx.com.
An online investor kit including press releases, current price quotes, stock charts and other valuable information for investors may be found at http://www.hawkassociates.com.
A profile for investors can be accessed at http://www.hawkassociates.com/clients/profile/wnmd.cfm.
To receive free e-mail notification of future releases for Wound Management, sign up at www.hawkassociates.com/about/alert/.
Safe Harbor Statement Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.
Contacts: Product information, contact Cathy Bradshaw at 954-315-9242. Shareholder relations, contact Lucy Singleton at 817-820-7080. Investor relations information, contact Frank Hawkins or Julie Marshall, Hawk Associates, at 305-451-1888 or email firstname.lastname@example.org.
SOURCE Wound Management Technologies, Inc.
|SOURCE Wound Management Technologies, Inc.|
Copyright©2009 PR Newswire.
All rights reserved